LifeMD, Inc. (NASDAQ: LFMD) announced that Atul Kavthekar will become its chief financial officer, effective March 16 2026. The company said former CFO Marc Benathen will remain in the role through March 31 to ensure a smooth transition.
Kavthekar brings nearly three decades of experience across healthcare, retail, specialty pharmacy, e‑commerce, and technology. In previous roles he has led financial operations for high‑growth companies, driving cost discipline, operational leverage, and capital allocation that supported rapid expansion. His background in specialty pharmacy and e‑commerce aligns closely with LifeMD’s vertically integrated pharmacy model and its focus on AI‑enabled virtual care.
LifeMD’s business strategy centers on scaling its virtual‑care and pharmacy services while expanding into high‑margin verticals such as weight management, women’s health, and behavioral health. The company is investing in an AI clinical decision‑support tool slated for launch in the first half of 2026, and it has broadened its weight‑management portfolio to include oral GLP‑1 medications. Kavthekar’s financial stewardship is expected to strengthen the company’s financial infrastructure, support the AI‑driven growth plan, and help manage the capital needs of these expansion initiatives.
For the full‑year 2025, LifeMD reported revenue of $194.1 million, up 25 % year‑over‑year, and adjusted EBITDA of $15.3 million. Management has guided 2026 revenue to $220 million–$230 million and adjusted EBITDA to $12 million–$17 million, projecting an annualized revenue run rate exceeding $250 million by Q4 2026. These figures reflect the company’s continued momentum in its core virtual‑care and pharmacy segments and the expected lift from its new high‑margin verticals.
The CFO transition underscores LifeMD’s commitment to maintaining financial discipline while pursuing aggressive growth. With Kavthekar’s experience in high‑growth environments and Benathen’s continued oversight through the transition period, the company aims to preserve operational stability and accelerate its strategic initiatives.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.